AI assistant
Marksans Pharma Ltd. — Major Shareholding Notification 2020
May 13, 2020
62142_rns_2020-05-13_7efacdc3-6705-41b7-9079-41c6b72b2f5b.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai — 400001. Bandra (E), Mumbai — 400051. Scrip Code: 524404 Symbol: MARKSANS
BSE Limited National Stock Exchange of India Limited
13 May, 2020
Sub: Disclosure under Regulation 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Dear Sirs,
Forwarding herewith disclosures made by Mr. Mark Saldanha and Mrs. Sandra Saldanha, promoters of Marksans Pharma Limited, under the provisions of Regulations 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.
Please note that due to lockdown on account of Covid 19 Pandemic, the above promoters are not in a position to provide a signed disclosure. However, we have received the above disclosure through mail from the promoters based on which this disclosure is being made through the Exchanges' disclosure portal in addition to the e-mail sent today.
Thanking you.
Yours faithfully, For Marksans Pharma Limited
Harshavardhan Panigrahi Company Secretary & Compliance Officer
Enclosed as above
CIN : L24110MH1992PLC066364 www.marksanspharma.com
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 © Tel.: +91 22 4001 2000 ¢ Fax : +91-22 4001 2011 E-mail: info@ marksanspharma.com
2" April, 2020
Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai — 400001. Bandra (E), Mumbai — 400051. Scrip Code: 524404 Symbol: MARKSANS
BSE Limited National Stock Exchange of India Limited
Sub: Disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Dear Sir,
We, the undersigned as promoters of Marksans Pharma Limited, hereby enclose disclosure of our shareholding in Marksans Pharma Limited as on 31°' March, 2020 pursuant to the Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Thanking you.
Yours faithfully,
Sd/- Sd/- Mark Saldanha Sandra Saldanha
Enclosed as above
CC.: Marksans Pharma Limited 11" Floor, Grandeur, Off Veera Desai Extension Road, Oshiwara, Andheri (West), Mumbai — 400053.
Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Part A: Details of Shareholding
| under Regulation Disclosures and 30(1) 30(2) of |
(Substantial SEBI |
Acquisition | Shares & of |
|---|---|---|---|
| Takeovers) Regulations, 2011 Part A: Details of Shareholding |
|||
| Name of the Target Company (TC) 1. |
MARKSANS PHARMA LIMITED | ||
| Name(s) of the Stock Exchange(s) where the 2. shares of the TC are listed |
1. The National Stock Exchange Limited 2. BSE Limited |
||
| Particulars of the shareholder 3. Name of person whose total holding (including a. that in the form of shares, warrants, convertible |
|||
| securities and any other instrument that would entitle the holder to receive shares in the target company) more than 25% share of the or is |
Not Applicable | ||
| voting rights of the TC. or |
|||
| member Name(s) promoter(s), the of of b. promoter group and Persons Acting in Concert (PAC) with him. |
1.Mr. Mark Saldanha 2.Mrs. Sandra Saldanha |
||
| Particulars of the holding of persons mentioned at 4. (3) above |
Number | % w.r.t. total share /voting capital wherever applicable |
of _ % total diluted share/voting capital of TC (*) |
| As on March 31* of the year 2020, holding of: a) Shares |
|||
| Mr. Mark Saldanha 1. |
197491553 | 48.25 | 48.24 |
| Mrs. Sandra Saldanha 2. |
180 | 0.00 | 0.00 |
| b) Voting Right (otherwise than by shares) | - | - | - |
| c) Warrants d) Convertible Securities |
- | - | - |
| e) Any other instruments that would entitle the | - - |
- - |
- - |
| holder to receive shares in the TC | |||
| TOTAL | 197491733 | 48.25 | 48.24 |
(*)Diluted shares/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. It includes 81314 equity shares that might be issued in case conversion right is exercised by all the holders of outstanding Foreign Currency Convertible Bonds of the TC.
Sd/- Sd/- Mark Saldanha Sandra Saldanha
Place: Mumbai Date: 2" April, 2020
Part B
Name of the Target Company (TC): Marksans Pharma Limited
| Part B | ||||
|---|---|---|---|---|
| Name of the Target Company (TC): Marksans Pharma Limited | ||||
| Names of the person and Persons Acting Concert(PAC) |
Whether the person belong to promoter or promoter group |
PAN of the person and PAC | ||
| with the person | ||||
| Mr. Mark Saldanha | ||||
| Yes |
Sd/- Sd/- Mark Saldanha Sandra Saldanha
Place: Mumbai Date: 2"? April, 2020 Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai — 400001. Bandra (E), Mumbai — 400051. Scrip Code: 524404 Symbol: MARKSANS
BSE Limited National Stock Exchange of India Limited
Sub: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Dear Sir,
We, the undersigned as promoters of Marksans Pharma Limited, hereby declare under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 that we have not made any encumbrance , directly or indirectly, of our shares held in Marksans Pharma Limited.
Thanking you.
Yours faithfully,
Sd/- Sd/- Mark Saldanha Sandra Saldanha
CC.: Audit Committee of Directors Marksans Pharma Limited 11" Floor, Grandeur, Off Veera Desai Extension Road, Oshiwara, Andheri (West), Mumbai — 400053.